MAP1LC3A and rheumatoid arthritis: To evaluate the effect of oridonin in combination with CQ on RA-FLSs, GFP-LC3 was transfected into RA-FLSs for 24 h, and then cells were treated with 100 μM CQ for 30 min, followed by treatment with 8 μg/mL oridonin for 24 h.